Antibodies to Insulin-like Growth Factor I Receptor

Details for Australian Patent Application No. 2007200793 (hide)

Owner Pfizer Inc. Abgenix, Inc.

Inventors Miller, Penelope E.; Cohen, Bruce D.; Moyer, James D.; Gallo, Michael; Beebe, Jean; Corvalan, Jose R.

Agent Cullen & Co

Pub. Number AU-A-2007200793

Parent 2002231368

Filing date 22 February 2007

Wipo publication date 15 March 2007

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 49/00 (2006.01) Preparations for testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

8 March 2007 Complete Application Filed

15 March 2007 Application Open to Public Inspection

  Published as AU-A-2007200793

28 August 2008 Alteration of Name

  The name of the applicant has been altered to Pfizer Inc.; Amgen Fremont Inc.

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007200794-Apparatus and Methods for Facilitating Wound Healing

2007200792-Network layer integration for supporting voice over internet protocol and internet protocol television services